Literature DB >> 27058639

STEAP4 and HIF-1α gene expressions in visceral and subcutaneous adipose tissue of the morbidly obese patients.

Fusun Ozmen1, M Mahir Ozmen2, Sibel Gelecek3, İsmail Bilgic3, Munevver Moran3, Tevfik Tolga Sahin4.   

Abstract

AIM AND
BACKGROUND: Obesity is a multifactorial disease in which environmental and genetic factors play an integrated role. Determining such target genes will help to elucidate the mechanisms underlying complex diseases such as obesity and diabetes which are usually seen together. Present study investigates the expression levels of STEAP4 and HIF-1α in visceral and subcutaneous adipose tissue. PATIENTS AND METHODS: 30(6M) morbidly obese patients undergoing bariatric surgery were included in the study. The patients were grouped according to the BMI as Group I (BMI <50kg/m(2)) and Group II (BMI ≥50kg/m(2)). Samples from visceral (omentum) and subcutaneous adipose tissues were obtained from each patient and real-time PCR (qPCR) was carried out for STEAP4 and HIF-1α gene expressions. Correlations between expression levels and clinical parameters were analyzed.
RESULTS: Mean age of the patients recruited to the study was 37.4 (18-64) years. Mean BMI was 46 (36-60) kg/m(2). STEAP4 expression in visceral adipose tissue was significantly higher than subcutaneous tissue. Visceral STEAP4 expression was also found to be reduced with increased BMI. It was also lower in patients with HbA1C over 6. Furthermore, expression of subcutaneous and visceral HIF-1α was significantly higher in Group II. There was a significant correlation between BMI, glycosylated hemoglobin, STEAP4 and HIF-1α gene expression.
CONCLUSIONS: Obesity and related disease are linked with the fact that there is a low grade inflammation in the adipose tissue of the obese individuals. Counter-regulatory processes such as STEAP4 protein family are overwhelmed by the proinflammatory stimuli. HIF-1α expression is increased due to tissue hypoxia and pro-inflammatory stimuli in the obese individuals, which results in increased visceral STEAP4 expressions.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adipose tissue; HIF-1α; Inflammation; Obesity; STEAP4

Mesh:

Substances:

Year:  2016        PMID: 27058639     DOI: 10.1016/j.molimm.2016.03.008

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  STEAP4 expression in human islets is associated with differences in body mass index, sex, HbA1c, and inflammation.

Authors:  Hannah M Gordon; Neil Majithia; Patrick E MacDonald; Jocelyn E Manning Fox; Poonam R Sharma; Frances L Byrne; Kyle L Hoehn; Carmella Evans-Molina; Linda Langman; Kenneth L Brayman; Craig S Nunemaker
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 2.  STEAP4: its emerging role in metabolism and homeostasis of cellular iron and copper.

Authors:  Rachel T Scarl; C Martin Lawrence; Hannah M Gordon; Craig S Nunemaker
Journal:  J Endocrinol       Date:  2017-06-02       Impact factor: 4.286

3.  STEAP4 Inhibits HIF-1α/PKM2 Signaling and Reduces High Glucose-Induced Apoptosis of Retinal Vascular Endothelial Cells.

Authors:  Lei Liu; Hui Xu; Hongyu Zhao; Chunying Jiang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-20       Impact factor: 3.168

4.  Overexpressing STAMP2 attenuates adipose tissue angiogenesis and insulin resistance in diabetic ApoE-/- /LDLR-/- mouse via a PPARγ/CD36 pathway.

Authors:  Feng Wang; Lu Han; Ran-Ran Qin; Yao-Yuan Zhang; Di Wang; Zhi-Hao Wang; Meng-Xiong Tang; Yun Zhang; Ming Zhong; Wei Zhang
Journal:  J Cell Mol Med       Date:  2017-06-19       Impact factor: 5.310

Review 5.  Oxygenation of adipose tissue: A human perspective.

Authors:  Ioannis G Lempesis; Rens L J van Meijel; Konstantinos N Manolopoulos; Gijs H Goossens
Journal:  Acta Physiol (Oxf)       Date:  2019-06-02       Impact factor: 6.311

6.  The expression of STEAP4 in peripheral blood predicts the outcome of septic patients.

Authors:  Haiyan Jiang; Yansong Dong; Dajun Yan; Yao Wu; Yue Wang; Yuting Ren; Guomin Mao; Guiwen Liang; Wei Liu; Yang Zhou; Zhongwei Huang; Lei Qi
Journal:  Ann Transl Med       Date:  2021-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.